GAVISCON TABLETS
GAVISCON TABLETS
Discontinued
DIN Number
02159783
Drug Class
Human
Market Date
Dec 31, 1996
Company
HC
glaxosmithkline consumer healthcare ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02159783
AIG Number0218288001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A02BX13 ALGINIC ACID
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification56:04.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
ALGINIC ACIDActive
Strength: 200 MG
Monograph: ALGINIC ACID
ALUMINUM HYDROXIDEActive
Strength: 80 MG
Monograph: ALUMINUM HYDROXIDE